Abstract:BACKGROUND: Myeloperoxidase (MPO), the enzyme of leukocytes, catalyzes the production of reactive halogen species, which can modify the structure of lipoproteins. Chlorination and nitration of tyrosine residues in apolipoprotein A-1 lead to the formation of dysfunctional high-density lipoproteins (HDL-p), thus blocking the reverse cholesterol transport. Low level of high-density lipoprotein cholesterol (HDL-C) is associated with exacerbation of coronary heart disease, but the prognostic value of this index is not fully assessed. AIM: The aim of this study was to examine a possible contribution of MPO to the atherosclerotic plaque development (the stable growth or the erosion and rupture) via the modification of HDL-p. That is to say we investigated the diagnostic values of measuring the total MPO (MPO-T), the active MPO (MPO-A) and the MPO/HDL-С relation in patients with hypertension and various forms of chronic coronary heart disease. MATERIALS AND METHODS: The cohort under study included 44 patients with arterial hypertension and chronic coronary heart disease. All patients were divided into three groups according to the diagnosis: arterial hypertension without coronary heart disease (Group I, n = 20); arterial hypertension and the initially stable chronic coronary heart disease without acute complications in the anamnesis (Group II, n = 14); arterial hypertension and myocardial infarction (acute coronary syndrome) in the anamnesis (Group III, n = 10). The enzyme-linked immunosorbent assay (ELISA) for MPO-T and specific immuno-extraction followed by enzymatic detection (SIEFED) by fluorogenic substrate for MPO-A were applied. After that the ratio MPO-T/HDL-C or MPO-A/HDL-C was calculated. RESULTS: The MPO-A and MPO-A/HDL-C ratio were significantly increased in the group III of patients with old myocardial infarction as compared with the patients of group II who had the initially stable coronary heart disease (p = 0.009 and p = 0.003, respectively). Besides, the level of HDL-C in the group III was significantly reduced (p = 0.013). Our measurements revealed the negative correlation between MPO-A and HDL-C concentrations (r = 0.31; p 0.05), which is in line with the presumption of the study accomplished. Surprisingly, the correlation between MPO-T/HDL-C ratio and that MPO-A/HDL-C was stronger (r = 0.72; p 0.05), than between MPO-T and MPO-A (r = 0.36; p 0.05). CONCLUSIONS: Our study demonstrates the importance of assessing MPO-T and MPO-A plasma concentrations and of calculating the ratio MPO/HDL-C as promising biomarkers in the complicated cases of chronic coronary heart disease. MPO-A and MPO-A/HDL-C values were elevated in the patients with old myocardial infarction, while the concentration of HDL-C remained decreased upon the transition from the acute to chronic phase of the disease.

Myeloperoxidase in the Plasma of Patients with Acute Coronary Syndrome

Early Clinical Screening Value of Myeloperoxidase in Acute Coronary Syndrome

[Prognostic Value of Myeloperoxidase Concentration in Patients with Acute Coronary Syndrome].

Clinical value of myeloperoxidase in early identification of acute coronary syndrome

Correlation Research of Myeloperoxidase and the Severity of Coronary Lesions in Patients with Acute Coronary Syndrome

Characteristics, prognostic determinants of monocytes, macrophages and T cells in acute coronary syndrome: protocol for a multicenter, prospective cohort study

Long-term Prognostic Value of Myeloperoxidase on Acute Coronary Syndrome: a Meta-Analysis.

The Value of Myeloperoxidase Plasma Levels Predict Risk in Patients with Unstable Angina

Correlation Analysis of Plasma Myeloperoxidase Level with Global Registry of Acute Coronary Events Score and Prognosis in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction.

[Value of Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1) and LOX-1 Mrna in Peripheral Mononuclear Cells in Early Diagnosis of Acute Coronary Syndrome].

Changes of Neutrophil Myeloperoxidase in Coronary Circulation among Patients with Acute Coronary Syndrome

Clinical implications of myeloperoxidase in patients with coronary artery disease

Clinical Significance of Neutrophil Myeloperoxidase on Peripheral Circulation in Acute Coronary Syndrome

Detection of serum CCL19,CCL21 and MPO in acute coronary syndrome

Myeloperoxidase/high-density lipoprotein cholesterol ratio in patients with arterial hypertension and chronic coronary heart disease

The Predictive Value of Myeloperoxidase for Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction.

Relative study on levels of serum myeloperoxidase and IL-6 with severity of coronary artery lesions in acute myocardial infarct

Elevated Levels of Platelet-Monocyte Aggregates and Related Circulating Biomarkers in Patients with Acute Coronary Syndrome.

Myeloperoxidase to high-density lipoprotein ratio: Potential predictor of severity and outcome in patients with acute ischemic stroke

Expression of Myeloperoxidase in Patient-Derived Endothelial Colony-Forming Cells—Associations with Coronary Artery Disease and Mitochondrial Function

[Plasma Matrix Metalloproteinases-2 and -9 Levels Are Elevated in Patients with Acute Coronary Syndrome and Coronary Chronic Total Occlusion].